Lacticin Q-mediated selective toxicity depending on physicochemical features of membrane components

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 5, 2011, Pages 2446-2450

  Yoneyama, Fuminori ^a   Ohno, Kanako ^a   Imura, Yuichi ^b   Li, Mengqi ^a   Zendo, Takeshi ^a   Nakayama, Jiro ^a   Matsuzaki, Katsumi ^b   Sonomoto, Kenji ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIOCIN; LACTICIN Q; UNCLASSIFIED DRUG;

ARTICLE; EXPERIMENTAL STUDY; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; MEMBRANE COMPONENT; NONHUMAN; OUTER MEMBRANE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN BINDING; TOXICITY;

BACTERIOCINS; CELL MEMBRANE; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; MICROBIAL SENSITIVITY TESTS; MODELS, BIOLOGICAL;

EID: 79955530001     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00808-10     Document Type: Article

References (31)

1. Bartlett, G. R. 1959. Phosphorus assay in column chromatography. J. Biol. Chem. 234:466-468.
2. Bauer, R., and L. M. Dicks. 2005. Mode of action of lipid II-targeting lantibiotics. Int. J. Food Microbiol. 101:201-216.
3. Bonelli, R. R., T. Schneider, H. G. Sahl, and I. Wiedemann. 2006. Insights into in vivo activities of lantibiotics from gallidermin and epidermin mode-of-action studies. Antimicrob. Agents Chemother. 50:1449-1457.
4. Breukink, E., and B. de Kruijff. 2006. Lipid II as a target for antibiotics. Nat. Rev. Drug Discov. 5:321-332.
5. Breukink, E., et al. 1999. Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic. Science 286:2361-2364. (Pubitemid 30016902)
6. Brogden, K. A. 2005. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat. Rev. Microbiol. 3:238-250.
7. Cao-Hoang, L., P. A. Marechal, M. Le-Thanh, and P. Gervais. 2008. Synergistic action of rapid chilling and nisin on the inactivation of Escherichia coli. Appl. Microbiol. Biotechnol. 79:105-109.
8. Chatterjee, C., M. Paul, L. Xie, and W. A. van der Donk. 2005. Biosynthesis and mode of action of lantibiotics. Chem. Rev. 105:633-684.
9. Cotter, P. D., C. Hill, and R. P. Ross. 2005. Bacteriocins: developing innate immunity for food. Nat. Rev. Microbiol. 3:777-788.
10. Dalet, K., Y. Cenatiempo, P. Cossart, and Y. Hechard. 2001. A σ(54)-dependent PTS permease of the mannose family is responsible for sensitivity of Listeria monocytogenes to mesentericin Y105. Microbiology 147:3263-3269. (Pubitemid 33150332)
11. Fimland, G., L. Johnsen, B. Dalhus, and J. Nissen-Meyer. 2005. Pediocin-like antimicrobial peptides (class IIa bacteriocins) and their immunity proteins: biosynthesis, structure, and mode of action. J. Pept. Sci. 11:688-696.
12. Fujita, K., et al. 2007. Structural analysis and characterization of lacticin Q, a novel bacteriocin belonging to a new family of unmodified bacteriocins of gram-positive bacteria. Appl. Environ. Microbiol. 73:2871-2877.
13. Gravesen, A., P. Warthoe, S. Knochel, and K. Thirstrup. 2000. Restriction fragment differential display of pediocin-resistant Listeria monocytogenes 412 mutants shows consistent overexpression of a putative β-glucoside-specific PTS system. Microbiology 146(Pt. 6):1381-1389. (Pubitemid 30364728)
14. Hechard, Y., C. Pelletier, Y. Cenatiempo, and J. Frere. 2001. Analysis of σ(54)-dependent genes in Enterococcus faecalis: a mannose PTS permease (EII(Man)) is involved in sensitivity to a bacteriocin, mesentericin Y105. Microbiology 147:1575-1580. (Pubitemid 32544822)
15. Hechard, Y., and H.-G. Sahl. 2002. Mode of action of modified and unmodified bacteriocins from Gram-positive bacteria. Biochimie 84:545-557. (Pubitemid 35350886)
16. Hirakura, Y., S. Kobayashi, and K. Matsuzaki. 2002. Specific interactions of the antimicrobial peptide cyclic β-sheet tachyplesin I with lipopolysaccharides. Biochim. Biophys. Acta 1562:32-36.
17. Loh, B., C. Grant, and R. E. Hancock. 1984. Use of the fluorescent probe 1-N-phenylnaphthylamine to study the interactions of aminoglycoside antibiotics with the outer membrane of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 26:546-551.
18. Martinez, B., et al. 2008. Specific interaction of the unmodified bacteriocin lactococcin 972 with the cell wall precursor lipid II. Appl. Environ. Microbiol. 74:4666-4670.
19. Matsuzaki, K. 1999. Why and how are peptide-lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes. Biochim. Biophys. Acta 1462:1-10.
20. Matsuzaki, K., K. Sugishita, N. Fujii, and K. Miyajima. 1995. Molecular basis for membrane selectivity of an antimicrobial peptide, magainin 2. Biochemistry 34:3423-3429.
21. Matsuzaki, K., et al. 1998. Relationship of membrane curvature to the formation of pores by magainin 2. Biochemistry 37:11856-11863. (Pubitemid 28400057)
22. O'Sullivan, L., R. P. Ross, and C. Hill. 2002. Potential of bacteriocin-producing lactic acid bacteria for improvements in food safety and quality. Biochimie 84:593-604. (Pubitemid 35350890)
23. Raetz, C. R., and C. Whitfield. 2002. Lipopolysaccharide endotoxins. Annu. Rev. Biochem. 71:635-700.
24. Twomey, D., R. P. Ross, M. Ryan, B. Meaney, and C. Hill. 2002. Lantibiotics produced by lactic acid bacteria: structure, function and applications. Antonie Van Leeuwenhoek 82:165-185.
25. Wiedemann, I., et al. 2006. Lipid II-based antimicrobial activity of the lantibiotic plantaricin C. Appl. Environ. Microbiol. 72:2809-2814.
26. Wiedemann, I., et al. 2006. The mode of action of the lantibiotic lacticin 3147-a complex mechanism involving specific interaction of two peptides and the cell wall precursor lipid II. Mol. Microbiol. 61:285-296.
27. Yoneyama, F., M. Fukao, T. Zendo, J. Nakayama, and K. Sonomoto. 2008. Biosynthetic characterization and biochemical features of the third natural nisin variant, nisin Q, produced by Lactococcus lactis 61-14. J. Appl. Microbiol. 105:1982-1990.
28. Yoneyama, F., et al. 2009. Lacticin Q, a lactococcal bacteriocin, causes high-level membrane permeability in the absence of specific receptors. Appl. Environ. Microbiol. 75:538-541.
29. Yoneyama, F., et al. 2009. Peptide-lipid huge toroidal pore, a new antimicrobial mechanism mediated by a lactococcal bacteriocin, lacticin Q. Antimicrob. Agents Chemother. 53:3211-3217.
30. Zasloff, M. 2002. Antimicrobial peptides of multicellular organisms. Nature 415:389-395. (Pubitemid 34100944)
31. Zhang, L., R. Benz, and R. E. Hancock. 1999. Influence of proline residues on the antibacterial and synergistic activities of α-helical peptides. Biochemistry 38:8102-8111.